Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.

Clinical trial NCT04780438 · UNKNOWN

Trial details

NCT number: NCT04780438
Sponsor: G.Gennimatas General Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Atrial Fibrillation Recurrent Pulmonary Venous Isolation Catheter Ablation Sodium-glucose Co-transporter 2 Inhibitors

Start date: 2021-09-01
Primary completion: 2023-09-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.